Best SellerPre-Order
Retatrutide 10mg
99.4% HPLC Purity4.9 (47)
Research-grade Retatrutide 10mg lyophilised powder — 99.4% HPLC purity, COA verified. Triple GLP-1/GIP/Glucagon receptor agonist for metabolic research.
$129.99AUD
ExclusivePre-Order
KLOW Peptide Blend 50mg
SKU: PW-005 • Batch: PW-260305
99.0% HPLC PurityCOA Verified ✓
4.9 (19 reviews)
$174.99AUD
Available — Pre-Order (7–10 days)
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Key Research Features
- Exclusive Peptide Labs formula
- 99.0% HPLC purity (combined)
- 50mg research-efficient size
- Multiple synergistic peptides at optimised ratios
- Full COA with component breakdown
- GMP-certified component sourcing
Molecular Details
- Sequence
- Proprietary multi-peptide blend — full component sequence data in COA
- Molecular Formula
- Multi-component proprietary blend (see COA for component formulae)
- Purity
- 99.0% (combined)
- Form
- Lyophilised powder
- Appearance
- White/off-white lyophilised powder
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Usage & Storage
- Quantity
- 50mg / vial
- Dosage Notes
- Research protocols depend on the target application and component composition. Refer to COA for component breakdown and published literature for individual component protocols.
- Reconstitution
- Reconstitute with 2–4mL bacteriostatic water. Swirl gently; do not shake. Allow to fully dissolve before use.
- Injection Route
- Subcutaneous (research protocols)
- Storage Temp
- −20°C for long-term storage
- Storage Conditions
- Store lyophilised at −20°C, protected from light. After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
- Packaging
- Sterile, tamper-evident research vial
Description
KLOW is our exclusive proprietary multi-peptide blend, available only from Peptide Labs. This advanced synergistic formula combines multiple research peptides at optimised ratios for complex research protocols.
The full component breakdown and individual compound specifications are documented in the Certificate of Analysis, which ships with every vial. All components are sourced from GMP-certified facilities and independently quality-tested before blending to ensure the final product meets our 99.0% combined purity specification.
The 50mg size provides significant research efficiency for labs conducting extended or multi-arm studies. At the listed purity, each milligram of KLOW Blend represents a precisely characterised multi-peptide research tool.
Research & Guides
Frequently Asked Questions — KLOW Blend
KLOW is an exclusive proprietary multi-peptide research blend developed by Peptide Labs. Full composition details are provided in the Certificate of Analysis.
The KLOW Blend is verified at 99.0% HPLC purity across all components.
No — KLOW is an exclusive Peptide Labs formula, not available from any other supplier.
Store lyophilised at −20°C. Once reconstituted, store at 2–8°C and use within 4 weeks.
Frequently Bought Together
Best SellerPre-Order
BPC-157 10mg
99.2% HPLC Purity4.9 (41)
Research-grade BPC-157 (Body Protection Compound) 10mg lyophilised powder. 99.2% HPLC purity, COA verified. Stable pentadecapeptide for tissue healing and gut research.
$89.99AUD
Pre-Order
GHK-Cu 50mg
99.3% HPLC Purity4.9 (53)
Research-grade GHK-Cu 50mg lyophilised powder — 99.3% HPLC purity, COA verified. Copper peptide complex for wound healing and skin research.
$94.99AUD
Research Use Only — Important Disclaimer
KLOW Peptide Blend 50mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations. Peptide Labs Australia ABN 55 947 727 521.